Halozyme Therapeutics
HALO
#2112
Rank
HK$57.56 B
Marketcap
HK$467.45
Share price
1.04%
Change (1 day)
43.31%
Change (1 year)

P/S ratio for Halozyme Therapeutics (HALO)

P/S ratio as of March 2025 (TTM): 7.30

According to Halozyme Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 20.4. At the end of 2024 the company had a P/S ratio of 6.03.

P/S ratio history for Halozyme Therapeutics from 2005 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.032.44%
20235.89-49.48%
202211.7-8.73%
202112.8-40.81%
202021.674.46%
201912.4-11.3%
201813.953.06%
20179.114.45%
20168.72-46.96%
201516.42.11%
201416.1-48.6%
201331.375.34%
201217.91.63%
201117.6-69.93%
201058.548.53%
200939.4-24.36%
200852.0-64.3%
2007146-74.13%
2006564-33.42%
2005847

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.59-23.38%๐Ÿ‡บ๐Ÿ‡ธ USA
18.2 149.47%๐Ÿ‡บ๐Ÿ‡ธ USA
1.30-82.23%๐Ÿ‡บ๐Ÿ‡ธ USA
2.47-66.09%๐Ÿ‡บ๐Ÿ‡ธ USA
3.11-57.42%๐Ÿ‡ซ๐Ÿ‡ท France
4.50-38.39%๐Ÿ‡บ๐Ÿ‡ธ USA